Sick Leave and Disability Pension in Prevalent Patients With Crohn’s Disease

Abstract

Work loss was found in approximately one-third of patients. The mean number of lost workdays was twice as high as in the comparators.

Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis: results from a nationwide study in Sweden

“…Strikingly, majority of the cost (56% for CD and 59% for UC) originated from productivity losses in the form of sick leave and disability pension. 25 These costs were two to three times higher than the general population comparators corresponding to an annual cost of $15 281 and $6786 attributable to CD and UC respectively.…”

<p>Work Loss in Relation to Pharmacological and Surgical Treatment for Crohn’s Disease: A Population-Based Cohort Study</p>

“…That patients with Crohn's disease have increased work loss, and that such work loss heavily depends on sociodemographic factors has been shown before, in both incident 21 and prevalent patients. 22 In patients starting treatment with TNF inhibitor, individuals with short education had 4.8 more lost workdays per month (ie twice as many) as individuals with long education, whereas when comparing patients starting treatment with TNF inhibitor (believed to have more severe disease) with patients starting aminosalicylate treatment (believed to have less severe disease), those starting TNF inhibitor treatment only had 1 more lost workday than those starting treatment with aminosalicylate. Socioeconomic factors thus seem to have a greater impact on work loss than disease severity.…”

“…In population-based studies, treatment with TNF inhibitors [22][23][24] and surgery [24][25][26][27][28] have been identified as risk factors for work disability. This association likely represents confounding by indication, in that disease severity and behaviour are associated with both the work disability and the treatment.…”

Berufsbezogene Problemlagen und erwünschte Unterstützungsangebote bei chronisch entzündlichen Darmerkrankungen

“…Das Risiko einer passageren wie einer dauerhaften Beeinträchtigung der Erwerbsfähigkeit bei CED-Betroffenen ist im Vergleich zur Bevölkerung deutlich erhöht: Es kommt zu häufigeren und längeren Arbeitsunfähigkeitszeiten, dauerhafte Erwerbsunfähigkeit und vorzeitiger Rentenbezug treten vermehrt auf [6][7][8][9][10][11][12]. Auch in Phasen klinischer Remission wird eine verringerte Arbeitsproduktivität am Arbeitsplatz beobachtet [13].…”